Richard Salvato

Mr. Richard Salvato

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Emerging Infectious Diseases
Verified
Journal Article
Open access
RSRichard Salvato
Richard Salvato
MIMaria Leticia Rodrigues Ikeda
Maria Leticia Rodrigues Ikeda
RBRegina Bones Barcellos
Regina Bones Barcellos
FGFernanda Godinho
Fernanda Godinho
PSPatrícia Sesterheim
Patrícia Sesterheim
GWGabriel Luz Wallau
Gabriel Luz Wallau
Healthcare Workers Infected with Monkeypox Virus, Brazil, 2022

1 September 2024 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
ACAline Scarpellini Campos
Aline Scarpellini Campos
AFAna Claúdia Franco
Ana Claúdia Franco
FGFernanda M. Godinho
Fernanda M. Godinho
RHRosana Huff
Rosana Huff
DCDarlan S. Candido
Darlan S. Candido
RSRichard Salvato
Richard Salvato
Western Equine Encephalitis Virus, South America

19 May 2025 in Current Research in Microbial Sciences
Verified
Journal Article
Open access
RSRichard Salvato
Richard Salvato
• Oropouche fever is emerging as a global public health concern. • A novel reassortant OROV lineage drives the 2023–2025 outbreak in the Americas. • Over 23,000 cases confirmed, with expansion into non-endemic regions. • OROV is linked to Guillain–Barré syndrome and congenital anomalies.

18 July 2021 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
RSRichard Salvato
Richard Salvato
ARAna Júlia Reis
Ana Júlia Reis
SSSun Hee Schiefelbein
Sun Hee Schiefelbein
MGMichael Andrés Abril Gómez
Michael Andrés Abril Gómez
SSStéphanie Steiner Salvato
Stéphanie Steiner Salvato
MRMaria Lucia Rosa Rossetti
Maria Lucia Rosa Rossetti

13 June 2019 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
RSRichard Salvato
Richard Salvato
SSS. Schiefelbein
S. Schiefelbein
RBR. B. Barcellos
R. B. Barcellos
BPB. M. Praetzel
B. M. Praetzel
IAI. S. Anusca
I. S. Anusca
MRM. L. R. Rossetti
M. L. R. Rossetti
Tuberculosis (TB) is the leading cause of death among infectious diseases worldwide. Among the estimated cases of drug-resistant TB, approximately 60% occur in the BRICS countries (Brazil, Russia, India, China and South Africa). Among Brazilian states, primary and acquired multidrug-resistant TB (MDR-TB) rates were the highest in Rio Grande do Sul (RS). This study aimed to perform molecular characterisation of MDR-TB in the State of RS, a high-burden Brazilian state. We performed molecular characterisation of MDR-TB cases in RS, defined by drug susceptibility testing, using 131Mycobacterium tuberculosis (M.tb)DNA samples from the Central Laboratory. We carried out MIRU-VNTR 24loci, spoligotyping, sequencing of thekatG,inhA andrpoB genes and RDRiosublineage identification. The most frequent families found were LAM (65.6%) and Haarlem (22.1%). RDRiodeletion was observed in 42 (32%) of theM.tbisolates. Among MDR-TB cases, eight (6.1%) did not present mutations in the studied genes. In 116 (88.5%)M.tbisolates, we found mutations associated with rifampicin (RIF) resistance inrpoB gene, and in 112 isolates (85.5%), we observed mutations related to isoniazid resistance inkatG andinhA genes. An insertion of 12 nucleotides (CCAGAACAACCC) at the 516 codon in therpoB gene, possibly responsible for a decreased interaction of RIF and RNA polymerase, was found in 19/131 of the isolates, belonging mostly to LAM and Haarlem families. These results enable a better understanding of the dynamics of transmission and evolution of MDR-TB in the region.

1 March 2020 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
RSRichard Salvato
Richard Salvato
ECElis Regina Dalla Costa
Elis Regina Dalla Costa
ARAna Júlia Reis
Ana Júlia Reis
SSSun Hee Schiefelbein
Sun Hee Schiefelbein
MHMaria Laura Halon
Maria Laura Halon
MRMaria Lucia Rosa Rossetti
Maria Lucia Rosa Rossetti